These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 20848537)

  • 1. The struggle within: microbial influences on colorectal cancer.
    Arthur JC; Jobin C
    Inflamm Bowel Dis; 2011 Jan; 17(1):396-409. PubMed ID: 20848537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex interplay between inflammation, the microbiota and colorectal cancer.
    Arthur JC; Jobin C
    Gut Microbes; 2013; 4(3):253-8. PubMed ID: 23549517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
    Bruner SD; Jobin C
    Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development.
    Kang M; Martin A
    Semin Immunol; 2017 Aug; 32():3-13. PubMed ID: 28465070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
    Ma Y; Zhang Y; Xiang J; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
    Front Cell Infect Microbiol; 2021; 11():599734. PubMed ID: 33738265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut microbial influence and probiotics on colorectal cancer].
    Myung DS; Joo YE
    Korean J Gastroenterol; 2012 Nov; 60(5):275-84. PubMed ID: 23172275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay between microbes and the immune response in inflammatory bowel disease.
    Goethel A; Croitoru K; Philpott DJ
    J Physiol; 2018 Sep; 596(17):3869-3882. PubMed ID: 29806140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and probiotics in colon tumorigenesis.
    Zhu Y; Michelle Luo T; Jobin C; Young HA
    Cancer Lett; 2011 Oct; 309(2):119-27. PubMed ID: 21741763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
    Frigerio S; Lartey DA; D'Haens GR; Grootjans J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways underlying IBD-associated colorectal neoplasia: therapeutic implications.
    Goel GA; Kandiel A; Achkar JP; Lashner B
    Am J Gastroenterol; 2011 Apr; 106(4):719-30. PubMed ID: 21386829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between intestinal microbiota and innate immune system in pediatric inflammatory bowel disease.
    Cucchiara S; Stronati L; Aloi M
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S64-6. PubMed ID: 22955361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of intestinal bacteria in human inflammatory bowel disease.
    Vanderploeg R; Panaccione R; Ghosh S; Rioux K
    Infect Dis Clin North Am; 2010 Dec; 24(4):977-93, ix. PubMed ID: 20937461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of lymphatic alterations in the pathogenesis and treatment of inflammatory bowel disease.
    Zhang L; Ocansey DKW; Liu L; Olovo CV; Zhang X; Qian H; Xu W; Mao F
    Biomed Pharmacother; 2021 Aug; 140():111752. PubMed ID: 34044275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease-Related Colorectal Neoplastic Lesions: The Role of Inflammation.
    Svrcek M; Borralho Nunes P; Villanacci V; Beaugerie L; Rogler G; De Hertogh G; Tripathi M; Feakins R;
    J Crohns Colitis; 2018 Nov; 12(12):1486-1498. PubMed ID: 30202940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of colorectal cancer in inflammatory bowel diseases.
    Nadeem MS; Kumar V; Al-Abbasi FA; Kamal MA; Anwar F
    Semin Cancer Biol; 2020 Aug; 64():51-60. PubMed ID: 31112753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive proteomic biomarkers for inflammatory bowel disease-associated cancer: where are we now in the era of the next generation proteomics?
    Park JM; Han NY; Han YM; Chung MK; Lee HK; Ko KH; Kim EH; Hahm KB
    World J Gastroenterol; 2014 Oct; 20(37):13466-2476. PubMed ID: 25309077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.